{"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"groups":[{"description":"plitidepsin + dexamethasone combination\n\nplitidepsin + dexamethasone: plitidepsin: powder and solvent for concentrate for solution for infusion. 2 mg vial + 4 ml ampoule. 5 mg/m2 intravenously (i.v.) over three hours on Day 1 and 15 every 4 weeks. dexamethasone: 4 mg tablet. 40 mg orally on Day 1, 8, 15 and 22 every four weeks at least one hour before plitidepsin infusion.","id":"BG000","title":"Plitidepsin+Dexamethasone"},{"description":"dexamethasone single agent\n\ndexamethasone: 4 mg tablet. 40 mg orally on Day 1, 8, 15 and 22 every four weeks.","id":"BG001","title":"Dexamethasone"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"88"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"124"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"83"},{"groupId":"BG001","value":"48"},{"groupId":"BG002","value":"131"}],"title":">=65 years"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"36","upperLimit":"85","value":"64"},{"groupId":"BG001","lowerLimit":"42","upperLimit":"85","value":"65"},{"groupId":"BG002","lowerLimit":"36","upperLimit":"85","value":"65"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"49"},{"groupId":"BG002","value":"123"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"97"},{"groupId":"BG001","value":"35"},{"groupId":"BG002","value":"132"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Race and Ethnicity were not collected from any participant.","title":"Race and Ethnicity Not Collected","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"7"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"33"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"Czechia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"18"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"United Kingdom"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"Portugal"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"20"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"19"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"Greece"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"8"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"New Zealand"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"28"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"Austria"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"South Korea"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}],"title":"Netherlands"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"68"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"99"}],"title":"PS 0"},{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"42"},{"groupId":"BG002","value":"116"}],"title":"PS 1"},{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"39"}],"title":"PS 2"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"PS 3"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"description":"ECOG PS, Eastern Cooperative Oncology Group performance status PS 0 Fully active, able to carry on all pre-disease performance without restriction PS 1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature PS 2 Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours PS 3 Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours PS 4 Completely disabled; cannot carry on any selfcare; totally confined to bed or chair PS 5 Dead","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG PS","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"7"}],"title":"Non Secretory"},{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"56"}],"title":"Secretory IgA"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"Secretory IgD"},{"measurements":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"51"},{"groupId":"BG002","value":"152"}],"title":"Secretory IgG"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Secretory IgM"},{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"37"}],"title":"Secretory Light chain disease"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"MM type at diagnosis","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"Stage A"},{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"30"}],"title":"Stage IA"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}],"title":"Stage IB"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"}],"title":"Stage II"},{"measurements":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"64"}],"title":"Stage IIA"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Stage IIB"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}],"title":"Stage III"},{"measurements":[{"groupId":"BG000","value":"85"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"128"}],"title":"Stage IIIA"},{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"21"}],"title":"Stage IIIB"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}],"title":"Not Durie-Salmon stage at diagnosis"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"description":"Stage I: small number of myeloma cells. All are present:Hemoglobin\\>100 g/L;Blood calcium\\<2.8 mmol/L;No areas of bone damage or a solitary plasmacytoma of the bone;IgG\\<50 g/L;IgA\\<30 g/L;Urine M-protein\\<4 g Stage II: Moderate number of myeloma cells. The features are between stage 1 and 3 Stage III: Large number of myeloma cells. One/more are present: Hemoglobin\\<85 g/L;Blood calcium\\>2.8 mmol/L;Several areas of bone damage;IgG\\>70 g/L;IgA\\>50 g/L;Urine M-protein\\>12 g Substage A: Kidney function is normal. Creatinine\\<180 µmol/L. Substage B: Kidney function is abnormal. Creatinine\\>=180 µmol/L","paramType":"COUNT_OF_PARTICIPANTS","title":"Durie-Salmon stage at diagnosis","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"72"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"105"}],"title":"Stage I"},{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"59"}],"title":"Stage II"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"38"}],"title":"Stage III"},{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"53"}],"title":"Not stage at diagnosis"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"description":"The International Staging System uses the results of 2 blood tests: albumin and beta-2-microglobulin level.\n\nStage I: Beta-2-microglobulin level less than 3.5 mg/L and albumin level more equal than 35 g/L.\n\nStage II: Beta-2-microglobulin level less than 3.5 mg/L and Albumin level less than 35 g/L or beta-2-microglobulin level is more than 3.5 mg/L but less than 5.5 mg/L and any albumin level.\n\nStage III: Beta-2-microglobulin is 5.5 mg/L or more and any albumin level.","paramType":"COUNT_OF_PARTICIPANTS","title":"International Staging System at diagnosis","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"34"},{"groupId":"BG001","value":"21"},{"groupId":"BG002","value":"55"}],"title":"Standard risk"},{"measurements":[{"groupId":"BG000","value":"38"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"54"}],"title":"High risk"},{"measurements":[{"groupId":"BG000","value":"99"},{"groupId":"BG001","value":"47"},{"groupId":"BG002","value":"146"}],"title":"NA/ND/UK"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"description":"NA: not available; ND: not done; UK: unknown.","paramType":"COUNT_OF_PARTICIPANTS","title":"Cytogenetic risk group at diagnosis","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"68"},{"groupId":"BG001","value":"35"},{"groupId":"BG002","value":"103"}],"title":"Yes"},{"measurements":[{"groupId":"BG000","value":"103"},{"groupId":"BG001","value":"49"},{"groupId":"BG002","value":"152"}],"title":"No"}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Prior radiotherapy","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"7","upperLimit":"14.6","value":"10.4"},{"groupId":"BG001","lowerLimit":"7.4","upperLimit":"14.6","value":"10.1"},{"groupId":"BG002","lowerLimit":"7","upperLimit":"14.6","value":"10.3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Hb","unitOfMeasure":"g/dL"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"11","upperLimit":"517","value":"140"},{"groupId":"BG001","lowerLimit":"24","upperLimit":"452","value":"154"},{"groupId":"BG002","lowerLimit":"11","upperLimit":"517","value":"144"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Platelets","unitOfMeasure":"platelets*10^9/L"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"21.9","upperLimit":"252.2","value":"72.9"},{"groupId":"BG001","lowerLimit":"23","upperLimit":"137","value":"69.4"},{"groupId":"BG002","lowerLimit":"21.9","upperLimit":"252.2","value":"71.9"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"description":"creatinine clearance","dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"CrCL","unitOfMeasure":"mL/min"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"0.1","upperLimit":"277.2","value":"71.8"},{"groupId":"BG001","lowerLimit":"19.5","upperLimit":"178.9","value":"70"},{"groupId":"BG002","lowerLimit":"0.1","upperLimit":"277.2","value":"71.3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Time from first diagnosis to randomization","unitOfMeasure":"months"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"-0.4","upperLimit":"83.1","value":"6.1"},{"groupId":"BG001","lowerLimit":"1.0","upperLimit":"101.7","value":"6.4"},{"groupId":"BG002","lowerLimit":"-0.4","upperLimit":"101.7","value":"6.2"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"description":"PD, Progressive disease .","dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Time from last PD/relapse to first study dose","unitOfMeasure":"weeks"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"0.0","upperLimit":"27.3","value":"4.1"},{"groupId":"BG001","lowerLimit":"0.2","upperLimit":"65","value":"4.2"},{"groupId":"BG002","lowerLimit":"0.0","upperLimit":"65","value":"4.1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Beta-2 microglobulin","unitOfMeasure":"mg/L"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"2","upperLimit":"6","value":"4"},{"groupId":"BG001","lowerLimit":"3","upperLimit":"7","value":"4"},{"groupId":"BG002","lowerLimit":"2","upperLimit":"7","value":"4"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"171"},{"groupId":"BG001","value":"84"},{"groupId":"BG002","value":"255"}],"units":"Participants"}]}],"dispersionType":"INTER_QUARTILE_RANGE","paramType":"MEDIAN","title":"Number of lines of prior systemic therapy","unitOfMeasure":"lines"}]}